MK-0457, a novel multikinase inhibitor, has activity in refractory AML, including transformed JAK2 positive myeloproliferative disease (MPD), and in Philadelphia-positive ALL.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Giles, F; Freedman, SJ; Xiao, A; Borthakur, G; Garcia-Manero, G; Wierda, W; Kornblau, SM; O'Brien, S; Bergstrom, DA; Rizzieri, DA

Published Date

  • November 16, 2006

Published In

Volume / Issue

  • 108 / 11

Start / End Page

  • 556A - 556A

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

International Standard Serial Number (ISSN)

  • 0006-4971